Invention Grant
- Patent Title: Substituted alpha-L-bicyclic nucleosides
- Patent Title (中): 取代的α-L-双环核苷
-
Application No.: US13063921Application Date: 2009-09-23
-
Publication No.: US08501805B2Publication Date: 2013-08-06
- Inventor: Punit P. Seth , Eric E. Swayze
- Applicant: Punit P. Seth , Eric E. Swayze
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Isis Pharmaceuticals, Inc. Patent Dept.
- Agent Casimir Jones
- International Application: PCT/US2009/058013 WO 20090923
- International Announcement: WO2010/036698 WO 20100401
- Main IPC: A61K31/343
- IPC: A61K31/343 ; C07D307/93

Abstract:
The present disclosure describes substituted α-L-bicyclic nucleoside analogs, oligomeric compounds prepared therefrom and methods of using the oligomeric compounds. More particularly, substituted α-L-bicyclic nucleoside analogs are provided, having one or more chiral substituents, that are useful for enhancing properties of oligomeric compounds including binding affinity. In some embodiments, the oligomeric compounds provided herein hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.
Public/Granted literature
- US20110166205A1 SUBSTITUTED ALPHA-L-BICYCLIC NUCLEOSIDES Public/Granted day:2011-07-07
Information query
IPC分类: